Skip to content
← Back to this collection

PUBLICATIONS · 36346962

Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2023 Mar 20
First author
Wang T

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2023 Jan;20(1):1. doi: 10.1038/s41571-022-00713-2.
    note
    Source null
    related pmid
    36418476
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2023 Mar 20;41(9):1646-1648. doi: 10.1200/JCO.22.02345.
    note
    Source null
    related pmid
    36634289
    relationship
    Comment in

Authors and identifiers

  1. name
    Wang T
    type
    Author
  2. name
    Tang Y
    type
    Author
  3. name
    Cai J
    type
    Author
  4. name
    Wan X
    type
    Author
  5. name
    Hu S
    type
    Author
  6. name
    Lu X
    type
    Author
  7. name
    Xie Z
    type
    Author
  8. name
    Qiao X
    type
    Author
  9. name
    Jiang H
    type
    Author
  10. name
    Shao J
    type
    Author
  11. name
    Yang F
    type
    Author
  12. name
    Ren H
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Wang T
    type
    Author
  2. name
    Tang Y
    type
    Author
  3. name
    Cai J
    type
    Author
  4. name
    Wan X
    type
    Author
  5. name
    Hu S
    type
    Author
  6. name
    Lu X
    type
    Author
  7. name
    Xie Z
    type
    Author
  8. name
    Qiao X
    type
    Author
  9. name
    Jiang H
    type
    Author
  10. name
    Shao J
    type
    Author
  11. name
    Yang F
    type
    Author
  12. name
    Ren H
    type
    Author
bibliography ids
  1. nci-bib-de5fd39a2ef1b90c605b0493
book metadata
content sha256
3b5f6ab5ffb068bbd83bf6591996102331d914442579c0e458f0f536e031a6e0
document type
citation
dois
  1. 10.1200/JCO.22.01214
electronic publication date
display
2022 Nov 8
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:36346962
immutable id
pubmed:36346962@3b5f6ab5ffb068bbd83bf6591996102331d914442579c0e458f0f536e031a6e0
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
9
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1670-1683
volume
41
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2023 Jan;20(1):1. doi: 10.1038/s41571-022-00713-2.
    note
    Source null
    related pmid
    36418476
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2023 Mar 20;41(9):1646-1648. doi: 10.1200/JCO.22.02345.
    note
    Source null
    related pmid
    36634289
    relationship
    Comment in
outcomes validated
false
pmid
36346962
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
c70563441a11774347dc67e4d831da52d88398ce67687c8094f45d44808378e1
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 Mar 20
precision
day
year
2023
publication types
  1. Clinical Trial, Phase II
  2. Multicenter Study
  3. Journal Article
  4. Research Support, N.I.H., Extramural
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36346962/
title
Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial.

Preserved source evidence · Not medical advice